HSA Approval

SUNGLUCON TABLET 5 mg

Approval Number

SIN10724P

Drug Name

Product Name

SUNGLUCON TABLET 5 mg

Approval Date

January 29, 1999

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

A10BB07

ATC Item Name

glipizide

Manufacturer Information

Pharmaceutical Manufacturer

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Manufacturers

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

Ingredient Name

GLIPIZIDE

Strength

5 mg

Drug MonographGlipizide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

SUNGLUCON TABLET 5 mg - HSA Approval | MedPath

AI-Powered Research

Premium Access

SUNGLUCON TABLET 5 mg

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal